Feraheme ferumoxytol regulatory update

The European Medicines Agency (EMA) accepted for filing an MAA from AMAG for Feraheme ferumoxytol to treat iron deficiency anemia in chronic kidney disease (CKD) patients. The IV iron replacement is ...